Photo courtesy of the Ministry of Health of Uzbekistan
The World Health Organization (WHO) and the U.S.-based St. Jude Children's Research Hospital have launched a project to provide high-quality cancer medications free of charge to several countries, aiming to improve pediatric oncology care. According to WHO’s press service, the first phase of the initiative will supply medicines to Mongolia and Uzbekistan.
WHO representatives confirmed that the initial stage is already underway. In total, the program will distribute cancer drugs to six countries: Mongolia, Uzbekistan, Zambia, Ecuador, Jordan, and Nepal. This year alone, approximately 5,000 children with cancer are expected to receive treatment under the initiative.
This project marks the first of its kind. These six nations were specifically chosen because, according to WHO, childhood cancer survival rates in low- and middle-income countries often fall below 30%.
Experts emphasize that the initiative will expand further. Over the next five to seven years, WHO plans to provide cancer medications to 50 countries, ultimately benefiting around 120,000 patients and reducing mortality rates.
«WHO is proud to be part of this joint initiative with St. Jude Children's Research Hospital, aimed at protecting health and bringing hope to children worldwide,» said WHO Director-General Tedros Ghebreyesus.
St. Jude Children's Research Hospital is a global leader in the study and treatment of cancer, sickle cell disease, and other life-threatening illnesses. Based in Memphis, Tennessee, it is the only pediatric cancer research hospital designated as a comprehensive cancer center by the U.S. National Cancer Institute.
